AbbVie Inc. (ABBV)

Exchange: New York Stock Exchange
Currency: USD

 
Price: 154.78 (Close)

Summary

 

52 Week range 200d Moving Avg. Beta
102.35 – 174.43 139.48 0.35
Dividend Dividend Yield Ex-Dividend date
5.34 3.44% 2022-04-13
P/E Ratio Latest EPS DGR 3 years
24.68 3.68 13.15%
Overvalued
Low
Very low Volatility
High
Slow
Dividend Growth
Fast

Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.

 

Sector: Industry:
Health Technology Pharmaceuticals: Major
Dividend Aristocrat

Environment, Social and Governance (ESG) Ratings

Total ESG Score

35 – 66 percentile

Environment

5 – 7 percentile

Social

23 – 7 percentile

Governance

16 – 7 percentile

Controversy level

3

MSCI ESG-Rating

BBB
see MSCI ESG rating explained

Peers

Dividend aristocrats in the same sector are:
– Cardinal Health Inc. (CAH)
– Abbott Laboratories (ABT)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)


Dividend Safety Metrics

Latest EPS 3.68
Annual Payout 5.34
Payout Ratio 145.11%
Dividend growth 25 Years
Dividend Score 81
Dividend Coverage Ratio 1.21
Altman-Z score 2.01 Grey Zone

 


Estimated Future Total Return Metrics

Total return last 5Y 22.70%
Dividend growth 5Y 17.93%
Current dividend yield 3.44%
Average dividend yield last 5Y 3.92%
Estimated EPS growth next 5Y 4.50%
Extra return due to over/under valuation -2.60%
Estimated future return 5Y (CAGR) 5.80%

 

AbbVie Inc. (ABBV) Valuation


AbbVie Inc. current dividend yield of 3.44% is -12% below its 5-year average. The 5-year average dividend yield is 3.92% (see red-line in chart). This indicates the stock looks overvalued today.

AbbVie Inc. (ABBV) Performance

The chart below displays the total price return(%) of AbbVie Inc. for different periods:

 

AbbVie Inc. (ABBV) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of AbbVie Inc. for different periods:

 


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
3.44 5.34 145.11% 25 Years

 

Dividend Growth Summary

3 Year Growth Rate (CAGR) 13.15%
5 Year Growth Rate (CAGR) 17.93%
10 Year Growth Rate (CAGR) 0.00%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2022 2.820 -%
2021 5.200 10.2%
2020 4.720 10.3%
2019 4.280 19.2%
2018 3.590 40.2%
2017 2.560 12.3%
2016 2.280 12.9%
2015 2.020 21.7%
2014 1.660 3.8%
2013 1.600 0.0%

AbbVie Inc. (ABBV) Dividend Payment History